Clinical Trials Browser

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Liver Neoplasms, Lymphoma, Melanoma, Stomach Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03383965 2017-12-27

CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas

Phase 1 Unknown

20 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic

NCT01983761 2013-11-18

Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation

Phase 1/2 Unknown

25 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes

NCT00441818 2008-05-09

Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma

Phase 1/2 Unknown

59 enrolled

Lymphoid

Hodgkin Disease

Clinical Trials

GB226

A Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Hodgkin's Lymphoma

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas

Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation

Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma